SCHEMBL3203841

SCHEMBL3203841

CC1=C(C)C([Si](C)(C)Nc2ccc(Br)cc2)C(C)=C1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.34
KMT2A Q03164 6/20 0.34
HTT P42858 2/20 0.34
RAPGEF4 Q8WZA2 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
MAPT P10636 6/20 0.33
KDM4E B2RXH2 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ALDH1A1 P00352 1/20 0.33
GALR3 O60755 1/20 0.33
LMNA P02545 1/20 0.32
TDP1 Q9NUW8 2/20 0.32
POLB P06746 2/20 0.32
GAA P10253 2/20 0.31
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PABPC1 P11940 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3206332 0.73 HTR1D (0.35) RAPGEF4ALDH1A1
SCHEMBL1172414 0.71 CYP2A6 (0.42) MEN1KMT2AHTTRAPGEF4CYP1A2
SCHEMBL2726453 0.68 MGLL (0.40) MAPTSMN1; SMN2ALDH1A1POLBNPC1
SCHEMBL3206650 0.66 RAPGEF4 (0.35) KMT2ARAPGEF4ALDH1A1
SCHEMBL18052297 0.63 CA1 (0.41) MEN1KMT2AHTTRAPGEF4CYP1A2
SCHEMBL467157 0.58
SCHEMBL4873588 0.57 ALDH1A1 (0.68) MEN1KMT2AHTTRAPGEF4CYP1A2
SCHEMBL6439666 0.57 MAPT (0.32) MEN1KMT2AMAPTKDM4EALDH1A1
SCHEMBL16526973 0.57 CYP2A6 (0.57) MEN1KMT2AHTTRAPGEF4MAPT
SCHEMBL17223076 0.57 CYP2A6 (0.57) MEN1KMT2AMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1960411-B1 HALOGEN SUBSTITUTED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2016-08-31 EP disclosed
US-7667064-B2 high weight average molecular weight while having a relatively narrow molecular weight distribution, resulting in high strength polyolefin; e.g. dimethylsilandiyl(eta 5-2-methyl-4-bromoinden-1-yl)(N-tert-butylamido)titanium dichloride EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-02-23 US disclosed
US-7667064-B2 high weight average molecular weight while having a relatively narrow molecular weight distribution, resulting in high strength polyolefin; e.g. dimethylsilandiyl(eta 5-2-methyl-4-bromoinden-1-yl)(N-tert-butylamido)titanium dichloride EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-02-23 US disclosed
US-20070135594-A1 Halogen substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
US-20070135594-A1 Halogen substituted metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135594-A1 Halogen substituted metallocene compounds for olefin polymerization MLX, AP1M1, AP2M1 MEN1 172/4885KMT2A 2734/4885HTT 4731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.